Sciele Pharma, Inc.
78
Plan:
39
64
87
0
10
20
30
40
50
60
70
80
90
100
For the average 401k participant, the 9 point difference between this plan's BrightScope Rating (78) and the top rated plan (87) could equate to:
[How is this calculated?]
[How is this calculated?]
6 additional years of work Up to $15,700 in lost retirement savings.The delay in retirement calculations apply solely to this defined contribution plan and do not take into account other retirement plans and programs offered by this employer.
Retirement Plan Description
Sciele Pharma, Inc. 401k Plan is a defined contribution plan with a profit-sharing component and 401k feature. This plan has a BrightScope Rating of 78, placing it in the top 15% of all plans in its peer group. This plan is also in the top 15% of plans for Company Generosity, Salary Deferral, and Total Plan Cost. Sciele Pharma, Inc. 401k Plan currently has over 1,100 active participants and over $33.3M in plan assets.
Retirement Plan Details
| Address |
Five Concourse Parkway, Suite 1800
Atlanta, GA 30328 |
| Industry | Drugs and Druggists' Sundries Merchant Wholesalers |
| Administrator | Michael Milligan |
| Net Plan Assets | $33,300,000 |
| Total Participants | 1,100 |
| Avg Account Balance | $30,000 |
Compare Other Companies in Peer Group
| Meridian Bioscience | 73.7 |
| Morris & Dickson Co., Ltd. | 73.5 |
| Herbalife International of America | 70.6 |
| The F. Dohmen Co. | 69.1 |
| Sunrider International | 66.9 |
| PDI | 61.5 |
Comments